References
Kim CJ, Day S, Yeh KA (2001) Gastrointestinal stromal tumors: analysis of clinical and pathologic factors. Am Surg 67:135–137
Miettinen M, Majidi M, Lasota J (2002) Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer 38(Suppl 5):S39–S51
Miettinen M, Monihan JM, Sarlomo-Rikala M, et al (1999) Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Path 23:1109–1118
DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231:51–58
Takahashi T, Kuwao S, Yanagihara M, Kakita A (1998) A primary solitary tumor of the lesser omentum with immunohistochemical features of gastrointestinal stromal tumors. Am J Gastroenterol 93:2269–2273
Kaiser AM, Beart RW Jr (2001) Surgical management of ulcerative colitis. Swiss Med Wkly 131:323–337
Chandrasoma P. Gastrointestinal pathology. Stamford, CT, Appleton & Lange
Fletcher CD, Berman JJ, Corless C, et al (2002) Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol 10:81–89
Koh JS, Trent J, Chen L, et al (2004) Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate. Histol Histopathol 19:565–574
Koay MH, Goh YW, Iacopetta B, et al (2005) Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases. Pathology 37:22–31
Corless CL (2004) Assessing the prognosis of gastrointestinal stromal tumors: a growing role for molecular testing. Am J Clin Pathol 122:11–13
Kim TW, Lee H, Kang YK, et al (2004) Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors. Clin Cancer Res 10:3076–3081
Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M (1998) CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Modern Pathol 11:728–734
Medeiros F, Corless CL, Duensing A, et al (2004) KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications. Am J Surg Pathol 28:889–894
Eisenberg BL, Judson I (2004) Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy. Ann Surg Oncol 11:465–475
Besana-Ciani I, Boni L, Dionigi G, Benevento A, Dionigi R (2003) Outcome and long term results of surgical resection for gastrointestinal stromal tumors (GIST). Scand J Surg 92:195–199
Demetri GD, von Mehren M, Blanke CD, et al (2002) Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472–480
Verweij J, Casali PG, Zalcberg J, et al (2004) Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial. Lancet 364:1127–1134
Grieco A, Cavallaro A, Potenza AE, et al (2002) Gastrointestinal stromal tumor (GIST) and ulcerative colitis. J Exp Clin Cancer Res 21:617–620
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaiser, A.M., Kang, JC., Tolazzi, A.R. et al. Primary Solitary Extragastrointestinal Stromal Tumor of the Greater Omentum Coexisting with Ulcerative Colitis. Dig Dis Sci 51, 1850–1852 (2006). https://doi.org/10.1007/s10620-006-9217-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-006-9217-y